Research Funding

Neuro-SysMed was originally established as a Centre for Clinical Treatment Research with funding from the Research Council of Norway (RCN). Since then, the Centre has worked to secure long-term funding for its research and to continue key initiatives beyond the original RCN funding period.

These efforts have resulted in several major grants from national and international funding organisations.

International organisations support research across several of Neuro-SysMed’s disease areas. For example, Cure Parkinson’s has recently awarded NOK 15 million to the SLEIPNIR project, while the EBV-MS Hop-On initiative has received NOK 5.5 million, strengthening international collaboration in multiple sclerosis (MS) research. SPARK-NS has also awarded NOK 22 million for a clinical trial investigating D-serine and a new collaboration in clinical trials.

National funding programmes support several of Neuro-SysMed’s clinical studies. KLINBEFORSK has awarded NOK 25 million to HYDRA, a clinical trial initiative in Parkinson’s disease (PD), and NOK 13 million to the MS project NEMESIS.

The Research Council of Norway supports several areas of the Centre’s research, including projects that aim to bring research discoveries closer to practical use and industry collaboration. Neuro-SysMed has also received funding for research infrastructure, in the form of equipment and shared resources that enable advanced research.

At the regional and institutional levels, Helse Vest and the University of Bergen (UiB) provide funding for research projects and research positions. This support is important both for carrying out research and for training new researchers and building expertise for the future.

Long-term research initiatives

Two major initiatives are helping to continue and further develop the research, expertise, and collaborations established through Neuro-SysMed.

The Mohn Center for Neuroprotection has been established with NOK 50 million in funding. The Centre will advance research into how nerve cells can be protected from damage and disease.

The SFI Innovation Center for Neuroresilience (ICoN) has received NOK 250 million in funding. The Centre will strengthen research and innovation and promote collaboration between research institutions and industry.

Together with other externally funded projects, these initiatives make it possible to build on the expertise, infrastructure, and partnerships developed through Neuro-SysMed. They also support continued research across diseases and disciplines, with the shared goal of improving diagnosis and treatment for people with neurological diseases.